Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Call for proposals
TPPs & TCPs
Learning resources for discovery scientists
Project of the year award
Computational chemistry
Global health compound design webinars
R&D challenges
Access
Products & projects
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Product maps
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
The road to health impact
Access challenges
Partnering
Our partner network
The PDP model
Socially responsible agreements
Our clinical centre partners
Our donors
Current donors
Past donors
Donate to MMV
Our impact
Achievements
Real life stories
Better medicines for children
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff map
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
MMV's internship programme
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Optimizing artemisinin production
Malaria online course
Newsroom
News & Press Releases
Films
Infographics
Interviews
Image slideshows
Publications
Audio
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
COVID Box
About the COVID Box
Request the COVID box
Supporting information
COVID Box terms and conditions
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
Pathogen Box
About the Pathogen Box
Exploiting the Pathogen Box
Pathogen Box research
Supporting information
Terms & conditions
Malaria Box
About the Malaria Box
Malaria Box Research
Supporting information
Terms & conditions
Map of box orders
Follow-up guidelines
Open Source Drug Discovery
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
427 found
MMV delivers testimony to US congress
05 Dec 2011
Marketing authorization for Eurartesim® announced at media roundtable
30 Nov 2011
New dual-acting antimalarial compounds discovered
17 Nov 2011
Partnership reaches important milestone
14 Nov 2011
Eurartesim® receives stringent regulatory approval from the EMA
10 Nov 2011
Patient screening underway for Pyramax® sub-study in Sotuba, Mali
09 Nov 2011
SMS for Life wins WSJ Innovation Award 2011
31 Oct 2011
MMV Symposium at EDCTP
20 Oct 2011
Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities
11 Oct 2011
Launch of the CAPSS Plus Pilot in Uganda
30 Sep 2011
Chinese scientist wins award for life-saving discovery of artemisinin
23 Sep 2011
Molecule moves through preclinical development in record time
02 Sep 2011
MMV ESAC member receives accolade for malaria research
22 Aug 2011
Pyramax® edges closer to patients
19 Aug 2011
The Ian Bathurst Sponsorship Programme
07 Jul 2011
MMV holds malaria session at The World Conference of Science Journalists
01 Jul 2011
MMV loses a dear colleague and friend
28 Jun 2011
Artemisinin’s key impurities identified and made available as reference standards
20 Jun 2011
MMV supports new technique to measure quality of artemisinin
06 Jun 2011
Ray Chambers takes over from Baroness Chalker as MMV's Chairman
01 Jun 2011
DHODH awarded MMV’s Project of the Year 2010
01 Jun 2011
MMV participates in Asia Pacific efforts to eliminate malaria
25 May 2011
Sanofi-aventis and MMV join forces to develop innovative malaria drugs
05 May 2011
Ray Chambers among TIME's Top 100
21 Apr 2011
Press briefing to mark World Malaria Day
21 Apr 2011
"SMS for Life" rolled-out nationwide in the United Republic of Tanzania
18 Apr 2011
MMV’s CEO delivers strong message at Oslo malaria conference
13 Apr 2011
Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria
18 Mar 2011
WHO: Low quality drugs continue to afflict Africa
25 Feb 2011
G-FINDER 2010: Good news with a twist in the tail for PDPs
18 Feb 2011
Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin
15 Feb 2011
Single-dose cure for malaria edges closer to the clinic
08 Feb 2011
MMV signs MoU with ALMA at the African Union Summit
03 Feb 2011
Ground-breaking trial underway to protect pregnant women from malaria
28 Jan 2011
WHO report calls for urgent action to protect malaria therapies
12 Jan 2011
Global plan for artemisinin resistance containment (GPARC)
11 Jan 2011
MMV's new CEO comes on board
05 Jan 2011
Letter from the CEO
22 Dec 2010
World Malaria Report shows scale-up of control activities is paying-off
14 Dec 2010
International status granted to three not-for-profit organizations in Switzerland
09 Dec 2010
WHO report calls for greater vigilance to allow early detection of artemisinin resistance
18 Nov 2010
MMV-supported artesunate for injection receives WHO prequalification
08 Nov 2010
Conclusive win of artesunate over quinine
08 Nov 2010
MMV announces new Chairman of the Board effective 2011
21 Oct 2010
Germany to give €20M to neglected disease research
20 Oct 2010
MMV appoints new CEO
12 Oct 2010
MMV ESAC member in Times Top 100 Scientists
11 Oct 2010
Optimizing development of combination therapies: the regulatory perspective
08 Oct 2010
Selecting the right partner drug: experts debate the issues
13 Sep 2010
MMV, Novartis and partners discover novel antimalarial drug candidate
03 Sep 2010
MMV becomes first PDP to make its IP freely available for neglected diseases research
16 Aug 2010
MMV to screen Ferrer compound library
15 Jul 2010
Malawi – determined to control malaria
14 Jul 2010
AstraZeneca and MMV join efforts in the fight against malaria
28 Jun 2010
Data from MMV-supported research now in the public domain
20 May 2010
Experts sought for Global Fund Technical Review Panel
14 May 2010
Over 5 million compounds screened
03 May 2010
MMV and Anacor join hands in hunt for new antimalarial compounds
26 Apr 2010
Ambrose Talisuna: Advocating for access
23 Apr 2010
MMV supports trials of a new preventive treatment option for pregnant women
23 Apr 2010
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »